Folia Biologica
Journal of Cellular and Molecular Biology, Charles University 

Crossref logo

Fol. Biol. 2003, 49, 235-237

https://doi.org/10.14712/fb2003049060235

No Association between Oxidative Stress and IL-6 in NIDDM Patients with Nephropathy

Ş. Alsancak1, M. Aydin2, A. Yildiz3, S. Salman2, Şule Seçkin1

1Department of Biochemistry, Istanbul Faculty of Medicine, Istanbul University, Çapa, Istanbul, Turkey
2Experimental Medical Research Institute, Istanbul Faculty of Medicine, Istanbul University, Çapa, Istanbul, Turkey
3Department of Nephrology, Istanbul Faculty of Medicine, Istanbul University, Çapa, Istanbul, Turkey

Received August 2003
Accepted October 2003

References

1. Baynes, J. W. (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405-412. <https://doi.org/10.2337/diab.40.4.405>
2. Buege, J. A., Aust, S. D. (1978) Microsomal lipid peroxidation. Methods Enzymol. 52, 302-310. <https://doi.org/10.1016/S0076-6879(78)52032-6>
3. Cooper, M. E. (2001) Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44, 1957-1972. <https://doi.org/10.1007/s001250100000>
4. Dasgubta, B., Messent, J. et al. (1991) Interleukin-6 in insulin dependent diabetes mellitus. Diabetes 40, (suppl. 1), 264A.
5. Feingold, K. F., Grunfeld, C. (1992) Role of cytokines in inducing hyperlipidemia. Diabetes 41, (suppl. 2), 97-101. <https://doi.org/10.2337/diab.41.2.S97>
6. Fukatsu, A., Matsuo, S. et al. (1991) Distribution of interleukin-6 in normal and diseased human kidney. Lab. Invest. 65, 61-66.
7. Ha, H., Kim, K. H. (1999) Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C. Diabetes Res. Clin. Pr. 45, 147-151. <https://doi.org/10.1016/S0168-8227(99)00044-3>
8. Hirano, T., Akira, S., Taga, T., Kishimoto, T. (1990) Biological and clinical aspects of interleukin 6. Immunol. Today 11, 443-449. <https://doi.org/10.1016/0167-5699(90)90173-7>
9. Kedziora-Kornatowska, K. Z., Luciak, M., Blaszczyk, J., Pawlak, W. (1998) Lipid peroxidation and activities of antioxidant enzymes in erythrocytes of patients with noninsulin dependent diabetes with or without diabetic nephropathy. Nephrol. Dial. Transplant. 13, 2829-2832. <https://doi.org/10.1093/ndt/13.11.2829>
10. Krolewski, A. S. (1999) Genetics of diabetic nephropathy. Kidney Int. 55, 1582-1596. <https://doi.org/10.1046/j.1523-1755.1999.00371.x>
11. Lehmann, R., Schleicher, E. D. (2000) Molecular mechanism of diabetic nephropathy. Clin. Chim. Acta 297, 135-144. <https://doi.org/10.1016/S0009-8981(00)00240-0>
12. Mooradian, A. D., Reed, R. L., Meredith, K. E., Scuderi, P. (1991) Serum levels of tumor necrosis factor and IL-1α and IL-1β in diabetic patients. Diabetes Care 14, 63-65. <https://doi.org/10.2337/diacare.14.1.63>
13. Sekizuka, K., Tomina, Y., Sei, C., Kurusu, A., Tashiro, K., Yamaguchi, Y., Kodera, S., Hishiki, T., Shirato, I., Koide, H. (1994) Detection of serum IL-6 in patients with diabetic nephropathy. Nephron 68, 284-285. <https://doi.org/10.1159/000188281>
14. Shikano, M., Sobajima, H., Yoshikawa, H., Toba, T., Kushimoto, H., Katsumata, H., Tomita, M., Kawashima, S. (2000) Usefulness of a highly sensitive urinary and serum IL-6 assay in patients with diabetic nephropathy. Nephron 85, 81-85. <https://doi.org/10.1159/000045634>
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Submissions

Archive